Abstract
Purpose. To evaluate the effectiveness of anti-tuberculosis chemotherapy regimens with the inclusion of linezolid in children and teenagers.Materials and methods. The results of treatment of 55 children and adolescents with tuberculosis when using linezolid in anti-tuberculosis therapy regimens were analyzed. Bacterial excretion was detected in 12.7% of patients at the start of therapy. All children and teenagers included in the study received at least 85% of the daily doses of anti-tuberculosis drugs.Results. All children and teenagers included in the study showed positive clinical and radiological dynamics at different periods of chemotherapy. Cessation of bacterial excretion was registered in all bacterial isolators by the end of the first month of treatment. The frequency of adverse reactions associated with the use of linezolid was 5.4%; all of them were reversible.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
